Cargando…
Outcome of dyslipidemic covid 19 patients in intensive care unit submitted to hemodialysis
Autores principales: | Martinez, T.L.R., Saldanha, A.L.R., Margeotto, A.P.P., Gasparoto, A.L., Guarnieri, F.H., Pereira, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415864/ http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.651 |
Ejemplares similares
-
Effect of Camellia sinensis teas on left ventricular hypertrophy and insulin resistance in dyslipidemic mice
por: Ferreira, M.C.L., et al.
Publicado: (2020) -
Dyslipidemic drugs in metabolic syndrome
por: Siddiqi, Sheelu S., et al.
Publicado: (2013) -
Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012) -
Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022) -
Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
por: Lemche, A. V., et al.
Publicado: (2016)